ClinicalTrials.gg
Not yet recruitingNCT07863544Updated Oct 7, 2026

Dexmedetomidine vs. Tramadol With Ropivacaine in Ultrasound-Guided PENG Block for Hip Surgery

An interventional study of Pericapsular nerve group block in Postoperative Pain, sponsored by Sargodha Medical College. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Sargodha Medical College · Not applicable, Interventional, and Prevention

Updated Oct 7, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

To compare the mean onset of sensory block and mean time to first rescue analgesia between ropivacaine with dexmedetomidine and ropivacaine with tramadol in ultrasound-guided pericapsular nerve group block for postoperative analgesia in patients undergoing hip surgeries.

02

Conditions studied

  • Postoperative Pain

Browse trials for

03

In context

Pain, Postoperative

5,224 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's planned enrollment of 66 is below the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Sargodha Medical College is the lead sponsor of 13 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 to 65years
  • Either gender
  • American Society of Anesthesiologists physical status I and II
  • Patients undergoing hip surgery under spinal anaesthesia

Exclusion criteria

Exclusion Criteria:

  • Known allergy to ropivacaine,dexmedetomidine,tramadol,ketorolac or bupivacaine
  • Contraindication to spinal anaesthesia or block,such as coagulopathy (INR above 1.5 or platelet count below 100,000/mm3) or local infection at the injection site
  • Bilateral,pathological or multiple fractures
  • Baseline heart rate below 60 beats per minute,heart block or use of beta blockers
  • Serum creatinine above 1.5mg/dL or history of peptic ulcer disease
  • History of seizures or use of antidepressants
  • Cognitive impairment or inability to understand the VAS
  • Pregnancy
  • Failed block (Hollmen grade below 3 at 30 minutes)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Other
    Ropivacaine and Tramadol

    Procedure: Pericapsular nerve group block

  • Other
    Ropivacaine with Dexmedetomidine

    Procedure: Pericapsular nerve group block

Interventions

  • ProcedurePericapsular nerve group block

    With the patient supine, a low-frequency curvilinear probe will be placed over the anterior inferior iliac spine and aligned with the superior pubic ramus. The needle will be inserted in-plane,lateral to medial,into the fascial plane between the psoas tendon and the superior pubic ramus,and the drug will be injected after negative aspiration.

06

What researchers measure

Primary outcomes

  1. Onset of sensory block

    Time frame: With in 30 minutes

  2. Time to first rescue analgesia

    Time frame: With in 24 hours

  3. Blood pressure

    Time frame: With in 24 hours

07

Study locations

1 site
  • Dr Faisal Masood teaching Hospital Sargodha
    Sargodha, Punjab Province 40100, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07863544
Lead sponsor
Sargodha Medical College
Responsible party
Sponsor
First posted
Oct 7, 2026
Start date
Oct 10, 2026 (estimated)
Primary completion
Aug 30, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Oct 7, 2026

Study contacts

Maham Maham Idrees, MBBS, FCPS Anesthesia
Contact
mahamidrees90009@gmail.com
03087506429

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion